AIOMEGA®
Investor Relations
Precision Airway Medicine
for Adult + Pediatric Care
AIOMEGA® develops clinician-directed intraoral medical devices for the treatment of obstructive sleep apnea. Our platform is built on engineering rigor, published clinical evidence, a growing intellectual property portfolio, and a disciplined commitment to responsible innovation.
The Opportunity
An Unmet Need in
Airway Medicine
Obstructive sleep apnea (OSA) is a prevalent, underdiagnosed, and undertreated condition affecting both adult and pediatric populations. Despite the availability of existing therapies, significant unmet need remains — particularly for patients who require alternatives to continuous positive airway pressure (CPAP) therapy.
Oral appliance therapy represents a clinician-directed, patient-accepted treatment pathway. AIOMEGA® has developed a precision platform — AIO Breathe® — that advances the standard of care through custom fabrication, structured clinical guidance, and published clinical evidence.
The pediatric OSA opportunity is particularly underserved. AIO Breathe® is one of the few FDA-cleared oral airway devices with published clinical evidence in the pediatric population (ages 6–17).
Adult OSA
A prevalent condition with significant unmet need for precision, clinician-directed oral appliance therapy.
Pediatric OSA
An underserved population. AIO Breathe® PDS is FDA-cleared for ages 6–17 with published clinical evidence.
Growing Platform
Published evidence across four studies supports the ongoing development and expansion of the AIOMEGA® platform.
Digital Precision
Fully digital fabrication workflow supports scalability, consistency, and quality across the platform.
AIO Breathe® Platform
A Precision Medical Platform
AIO Breathe® is a custom-fabricated, FDA-cleared oral airway device designed to be prescribed and managed by licensed clinicians. The platform integrates clinical medicine, engineering biomechanics, and precision digital fabrication into a unified system.
Adult Platform
AIO Breathe®
FDA-cleared for the treatment of mild to moderate obstructive sleep apnea and snoring in patients 18 years and older. Custom-fabricated to the clinician’s prescription through a fully digital workflow.
- FDA-cleared prescription medical device
- Patients 18 years and older
- Custom-fabricated to clinician prescription
- Clinician-directed care model
- Published clinical evidence: n=50, n=200, n=250
Pediatric Platform
AIO Breathe® PDS
FDA-cleared for the treatment of mild to moderate obstructive sleep apnea and snoring in patients ages 6 through 17. Growth-conscious, dentition-adaptive, and airway-centric design.
- FDA-cleared prescription medical device
- Patients ages 6 through 17
- Growth-conscious, dentition-adaptive design
- Airway-centric, TMJ-friendly platform
- Published clinical evidence: Ages 6–17
Precision Digital Fabrication
AIO Breathe® is fabricated through a fully digital workflow — from clinician-submitted records through CAD/CAM engineering, precision SLA printing, and structured quality verification. Each device is custom-fabricated to the clinician’s prescription, supporting consistency, accuracy, and scalability across the platform.
Published Clinical Evidence
Evidence Published in SLEEP
AIO Breathe® clinical evidence has been published in SLEEP — the official journal of the Sleep Research Society. AIOMEGA® does not make outcome claims beyond what is supported by published evidence.
Adult Pilot Study
SLEEP Vol. 48, Supp. 1, 2025
View Published Study n=200Adult Expanded Study
SLEEP Vol. 49, Supp. 1, 2026
View Published Study n=250Adult Outcomes Study
SLEEP Vol. 49, Supp. 1, 2026
View Published Study Ages 6–17Pediatric Study
SLEEP Vol. 49, Supp. 1, 2026
View Published StudyPublished studies are available for clinician and investor review. AIOMEGA® does not make outcome claims beyond what is supported by published peer-reviewed evidence. Study results are as reported in the published abstracts.
Regulatory Foundation
FDA-Cleared.
Quality-Committed.
AIO Breathe® is FDA-cleared for the treatment of mild to moderate obstructive sleep apnea and snoring in both adult and pediatric patients. AIOMEGA® operates within the regulatory framework governing prescription medical devices.
Our development approach is informed by established regulatory principles and quality-system expectations, including QMSR-aligned quality practices, ISO 13485-style design controls, and ISO 10993-compliant material selection.
FDA Clearance
AIO Breathe® is FDA-cleared for adult (18+) and pediatric (ages 6–17) patients. Prescription-only medical device.
Quality System
QMSR-aligned quality practices, ISO 13485-style design controls, validated manufacturing workflows, and device-level traceability.
Material Compliance
ISO 10993-compliant material selection. Biocompatibility is a foundational requirement of the AIOMEGA® platform.
Post-Market Surveillance
Structured post-market surveillance and ongoing integration of published clinical evidence into the platform.
Intellectual Property
A Protected Innovation Portfolio
AIOMEGA® has developed and protects a portfolio of intellectual property covering the AIO Breathe® device platform, clinical methodology, and associated technologies. The portfolio is assigned to Sleep Solutions of Texas, LLC.
Patents
Issued and pending patents covering intraoral device geometry, mandibular positioning systems, digital workflows, and biomechanical modeling.
Trademarks
Registered and pending trademarks covering the AIOMEGA® medical device brands and clinical education platform.
Proprietary Know-How
Proprietary clinical and technical know-how protected through AIOMEGA-controlled channels.
Controlled Education
The AIOMEGA Breathe Academy™ curriculum is proprietary. Clinician training is delivered exclusively by AIOMEGA.
IP Portfolio Assignment
The AIOMEGA® intellectual property estate is assigned to Sleep Solutions of Texas, LLC. A full list of granted and pending patents is available upon request. This summary is provided for informational purposes only and does not disclose proprietary internal logic or unpublished technologies.
AIOMEGA Breathe Academy™
Built by AIOMEGA.
Taught by AIOMEGA.
The AIOMEGA Breathe Academy™ is AIOMEGA’s proprietary clinician education platform. It provides structured, AIOMEGA-led training for licensed clinicians seeking to prescribe and manage AIO Breathe®.
The Academy delivers in-person training, live remote instruction, and controlled clinician resources — all through AIOMEGA-controlled channels. The proprietary curriculum is not publicly disclosed.
The Academy creates a structured, ongoing relationship between AIOMEGA® and the clinicians who prescribe AIO Breathe® — supporting platform consistency, clinical quality, and long-term clinician engagement.
AIOMEGA-Led Training
All clinician training is delivered directly by AIOMEGA. No third-party curriculum delivery.
In-Person Training
Structured in-person training formats for clinicians entering the AIOMEGA platform.
Live Remote Instruction
Live Zoom-based remote training options for clinicians across geographies.
Controlled Resources
Clinical documentation and resources are delivered through the AIOMEGA operational portal.
Ongoing Clinician Relationship
The Academy supports a structured, long-term relationship between AIOMEGA and prescribing clinicians.
AIOMEGA Ecosystem
An Integrated Platform
AIOMEGA® operates as an integrated ecosystem — connecting the clinical device platform, the clinician education system, the digital portal, and the public-facing information architecture into a unified whole.
AIO Breathe®
FDA-cleared oral airway device. Adult + pediatric. Custom-fabricated. Clinician-directed.
AIOMD.COM
The authoritative public information platform for clinicians, patients, partners, and investors.
AIOMEGA Portal
The operational portal for credentialed clinicians. Case management, resources, and clinical support.
Breathe Academy™
AIOMEGA-led clinician education. Structured training, controlled resources, ongoing relationship.
Leadership
Founded by a Sleep Physician
AIOMEGA® was founded by Raghavendra V. Ghuge, MD, DABSM, FAASM, MBA — an adult and pediatric sleep physician with more than 20 years of clinical experience in sleep medicine.
Dr. Ghuge combines medical training with engineering-driven device development and business expertise from the Duke University Fuqua School of Business. His work spans clinical care, invention, intellectual-property development, and the creation of clinician-directed digital workflows that emphasize safety, clarity, and responsible innovation.
AIOMEGA® is headquartered in Tyler, Texas.
Strategic Inquiry
Investor & Partnership Inquiries
AIOMEGA® welcomes discussions with strategic investors and partners who share our commitment to responsible development, clinical clarity, and long-term value creation in precision airway medicine.
Please Include
- Your name and organization
- Contact information
- Area of interest
- Nature of inquiry
Informational Purposes Only
This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. AIOMEGA® is a registered trademark of Sleep Solutions of Texas, LLC. © 2026 AIOMEGA®. All rights reserved.